{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-26-104109","form_type":"8-K","ticker":"ENTA","cik":"0001177648","company_name":"ENANTA PHARMACEUTICALS INC","filed_at":"2026-03-12T23:59:59+00:00","discovered_at":"2026-05-14T18:02:34.645868+00:00","generated_at":"2026-05-15T12:57:19.515581+00:00","sec_items":["5.02","5.07","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"Enanta stockholders approve 1.6M share increase to 2019 Equity Plan; re-elect directors","bullets":["Stockholders re-elected Bruce L.A. Carter and Jay R. Luly as Class I directors with 20.3M and 24.7M votes for, respectively.","Amendment to 2019 Equity Incentive Plan approved (19.5M for, 5.4M against), increasing share reserve by 1,600,000 shares.","Advisory say-on-pay vote approved with 24.2M for, 692k against.","Ratification of PricewaterhouseCoopers as independent auditor for fiscal 2026 approved (26.8M for, 27k against)."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-26-104109","json":"https://secwatch.observer/filing/0001193125-26-104109.json","markdown":"https://secwatch.observer/filing/0001193125-26-104109.md","text":"https://secwatch.observer/filing/0001193125-26-104109.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1177648/000119312526104109/0001193125-26-104109-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1177648/000119312526104109/enta-20260311.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-15T12:57:19.515581+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}